Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ABBOTT LABORATORIESABT · Entity 2314 | Senior Vice President | December 06, 2013 | February 04, 2013 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ABBOTT LABORATORIES
Report date December 06, 2013 · Filed February 04, 2013
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common shares without par valueSEC Table I · non-derivative | Direct | 79,747 |
Ending reported balance
After 2012-12-07 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2012-12-06 · Gift · Disposed 7,700 · Balance 83,447 Row 2 · 2012-12-07 · Gift · Disposed 3,700 · Balance 79,747 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $53.27 | $15,981.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 6 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,122 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $53.27 | $5,326.50 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 5 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,422 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,400 | $53.26 | $181,084.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 4 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,522 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,200 | $53.25 | $63,900.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,922 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,000 | $53.24 | $53,240.00 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 188,122 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:19 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Exercise / conversionCommon shares without par value | 98,470 | $21.92 | $2,158,462.40 |
DisclosureSEC source: 0001179110-11-014485 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,122 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,300 | $53.58 | $123,234.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 30 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,337 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $53.58 | $5,357.75 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 29 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,637 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $53.58 | $69,647.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 28 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,737 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,900 | $53.57 | $155,353.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 27 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,037 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.57 | $10,713.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 26 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,937 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $53.57 | $5,356.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 25 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,137 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $53.56 | $21,424.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 24 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,237 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $53.56 | $26,777.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 23 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,637 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 500 | $53.55 | $26,775.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 22 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,137 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 3,000 | $53.55 | $160,635.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 21 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,637 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,400 | $53.54 | $74,956.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 20 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,637 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $53.54 | $5,353.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 19 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,037 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,100 | $53.53 | $112,413.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 18 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,137 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,900 | $53.52 | $101,688.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 17 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,237 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,254 | $53.51 | $67,101.54 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 16 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,137 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,950 | $53.50 | $157,825.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 15 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,391 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,100 | $53.49 | $58,839.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 14 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,341 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,800 | $53.48 | $149,744.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 13 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,441 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 900 | $53.48 | $48,127.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 12 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,241 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 4,300 | $53.47 | $229,921.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 11 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,141 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.47 | $10,693.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 10 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,441 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,600 | $53.46 | $85,536.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 9 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,641 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $53.46 | $16,036.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 8 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,241 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,592 | $53.45 | $352,342.40 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 7 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,541 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 300 | $53.45 | $16,033.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 6 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,133 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 6,600 | $53.44 | $352,704.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 5 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,433 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.44 | $10,687.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 4 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,033 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $53.42 | $5,342.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,233 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 100 | $53.42 | $5,341.50 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,333 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,300 | $53.41 | $69,433.00 |
DisclosureSEC source: 0001179110-11-014486 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,433 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 400 | $53.61 | $21,444.00 |
DisclosureSEC source: 0001179110-11-014487 · edgar.xml · nonDerivative · entry 4 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,652 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 1,685 | $53.60 | $90,316.00 |
DisclosureSEC source: 0001179110-11-014487 · edgar.xml · nonDerivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,052 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 2,400 | $53.59 | $128,616.00 |
DisclosureSEC source: 0001179110-11-014487 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,737 Read SEC document |
| October 24, 2011 Filed Oct 26, 2011 22:20 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $53.59 | $10,717.00 |
DisclosureSEC source: 0001179110-11-014487 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,137 Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 648 | $47.98 | $31,092.98 |
DisclosureSEC source: 0001179110-11-003745 · edgar.xml · nonDerivative · entry 5 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,652 Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 200 | $47.98 | $9,596.00 |
DisclosureSEC source: 0001179110-11-003745 · edgar.xml · nonDerivative · entry 4 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,300 Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | SaleCommon shares without par value | 806 | $47.99 | $38,679.94 |
DisclosureSEC source: 0001179110-11-003745 · edgar.xml · nonDerivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,500 Read SEC document |
| February 28, 2011 Filed Mar 1, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 2,822 | $47.64 | $134,440.08 |
DisclosureSEC source: 0001179110-11-003745 · edgar.xml · nonDerivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,306 Read SEC document |
| February 26, 2011 Filed Mar 1, 2011 22:02 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 3,668 | $47.64 | $174,743.52 |
DisclosureSEC source: 0001179110-11-003745 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,128 Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantOption (right to buy) · Derivative | 31,200 | $0.00 Strike: $46.60 | $0.00 |
DisclosureSEC source: 0001179110-11-003270 · edgar.xml · derivative · entry 2 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,200 Underlying: Common shares · 31,200 shares Expires 2021-02-17 F2 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 10,400 on 02/18/2012, 10,400 on 02/18/2013, and 10,400 on 02/18/2014. Read SEC document |
| February 18, 2011 Filed Feb 23, 2011 22:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value | 22,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-11-003270 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,796 F1 · shares: These shares represent performance vested restricted stock awards under the Abbott Laboratories 2009 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes. Read SEC document |
| August 26, 2010 Filed Aug 26, 2010 21:10 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 9,336 | $49.82 | $465,119.52 |
DisclosureSEC source: 0001179110-10-013229 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,596 Read SEC document |
| February 26, 2010 Filed Mar 2, 2010 23:52 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | Tax withholdingCommon shares without par value | 4,668 | $54.12 | $252,632.16 |
DisclosureSEC source: 0001179110-10-004238 · edgar.xml · nonDerivative · entry 1 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,932 Read SEC document |
| February 19, 2010 Filed Feb 24, 2010 01:43 UTC | ABBOTT LABORATORIES ABT · Entity 2314 | GrantCommon shares without par value · Derivative | 28,700 | $0.00 Strike: $54.50 | $0.00 |
DisclosureSEC source: 0001179110-10-003577 · edgar.xml · derivative · entry 3 MAZZO JAMES V · CIK 0001227297 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,700 Underlying: Common Shares · 28,700 shares Expires 2020-02-18 F3 · security: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 9,567 on 2/19/2011, 9,566 on 2/19/2012, and 9,567 on 2/19/2013. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.